By the end of 2021, the doses could be delivered to countries to vaccinate the highest-risk people, including healthcare workers, people over 65, and older adults with comorbidities, the plan states.
The plan, part of WHO’s Access to COVID-19 Tools Accelerator, or ACT-Accelerator, program, is estimated to cost $18.1 billion, according to STAT.
The Coalition for Epidemic Preparedness Innovations, or CEPI, and Gavi, the Vaccine Alliance are partnering with the WHO to execute the plan.
According to the plan, countries will be offered shares of nine vaccines in development that are supported by CEPI. Since it isn’t known which vaccine will work, purchasing shares in a pool — which will be called the Covax facility — will enhance a country’s chance of having access to a vaccine, STAT reported. It’s also expected that charitable donors will help support shares of the vaccine for low and middle income countries.
Read the full article here.
More articles on supply chain:
Medical supply makers’ trade group creates COVID-19 exchange site
9 brands of hand sanitizer may be toxic, FDA says
FEMA paid company $7M for test tubes, received plastic soda bottles
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
